GO:0015854 guanine transport: Purine Salvage and Nucleotide Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015854 (guanine transport) describes the directed movement of guanine, 2-amino-6-hydroxypurine, into, out of or within a cell, or between cells, by means of a transporter or pore.
• Guanine transport is essential for purine salvage, nucleotide biosynthesis, and cellular homeostasis in organisms ranging from protozoan parasites to mammals.
• Key transporters include members of the nucleobase-ascorbate transporter (NAT) family, such as PfNT1 in Plasmodium falciparum, and SLC35F2, a high-specificity transporter for queuine and queuosine.
• In the brain, guanine and guanosine transport in astrocytes and neurons is critical for purine recycling and neuromodulation.
• Aza-guanine transporters from Paenibacillus larvae and cytokinin transporters (AZGs) highlight the evolutionary diversity of guanine-related transport systems.
• Dysregulation of guanine transport is linked to parasitic infections, cancer, and neurological disorders, making it a target for drug development and CRISPR-based functional studies.
Description
Guanine transport (GO:0015854) is the biological process by which the purine nucleobase guanine is moved across cellular membranes or between cellular compartments via specific transporters or pores. This process is fundamental for purine salvage, allowing cells to recycle guanine for nucleotide synthesis and energy metabolism. In protozoan parasites such as Plasmodium falciparum, guanine transport is essential for parasite survival, as these organisms rely on salvage pathways due to their inability to synthesize purines de novo. In mammals, guanine transport in the central nervous system contributes to purine homeostasis and neuromodulation. Recent studies have identified SLC35F2 as a high-specificity transporter for queuine and queuosine, expanding the known repertoire of guanine-related transport proteins. Understanding guanine transport is therefore critical for dissecting nucleotide metabolism, host-pathogen interactions, and neurological function.
guanine transport At A Glance
| GO ID | GO:0015854 |
|---|---|
| GO term | guanine transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of guanine across membranes via transporters or pores |
| Related processes | Purine salvage, nucleotide metabolism, nucleobase transport |
| Key transporters | PfNT1, SLC35F2, AZG transporters, NAT family members |
| Organisms studied | Plasmodium falciparum, mammals, honey bee pathogen Paenibacillus larvae, plants |
What Is GO:0015854?
According to the Gene Ontology, GO:0015854 (guanine transport) is defined as the directed movement of guanine, 2-amino-6-hydroxypurine, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the translocation of guanine across biological membranes, facilitated by specific transport proteins, and is distinct from the transport of other purines such as adenine or xanthine.
Why Is guanine transport Important in Cell Biology?
Guanine transport is vital for cellular purine homeostasis and is a critical vulnerability in pathogens that lack de novo purine synthesis, such as Plasmodium falciparum. In humans, efficient guanine transport supports nucleotide pools in rapidly dividing cells and contributes to brain purine metabolism. The identification of SLC35F2 as a transporter for queuine and queuosine links guanine transport to tRNA modification and translational fidelity. Moreover, guanine-based amphiphiles have been shown to exhibit ion transport properties and biological activity, suggesting potential therapeutic applications. Thus, guanine transport is a nexus of metabolism, infectious disease, and cancer biology.
• Essential for purine salvage in parasites like Plasmodium falciparum, which cannot synthesize purines de novo.
• Supports nucleotide biosynthesis and energy metabolism in mammalian cells.
• Contributes to neuromodulation and purine recycling in the central nervous system.
• SLC35F2-mediated transport of queuine/queuosine influences tRNA modification and translation.
• Aza-guanine transporters in Paenibacillus larvae reveal mechanisms of nucleobase uptake in pathogens.
• Cytokinin transporters (AZGs) in plants are structurally related to guanine transporters, linking purine transport to plant development.
• Guanine-based amphiphiles can act as ion transporters, with potential antibacterial or anticancer activity.
• Prodrug transport through SLC15 family members highlights the pharmacological relevance of nucleobase transporters.
• Nucleocytoplasmic transport mechanisms provide a framework for understanding directed movement of purines.
• Dysregulated guanine transport may contribute to drug resistance and metabolic reprogramming in cancer.
What Happens During guanine transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and grabs guanine.
Guanine transporters exhibit high specificity for guanine over other purines. For example, PfNT1 in Plasmodium falciparum transports guanine, xanthine, guanosine, and adenine, but with distinct affinities. SLC35F2 is a high-specificity transporter for queuine and queuosine, which are structurally related to guanine. In rat cortical astrocytes and neurons, guanine transport is saturable and temperature-dependent, indicating protein-mediated uptake. The initial step involves binding of guanine to the transporter's substrate pocket, often coupled to ion gradients.
Translocation Across the Membrane
In simple terms: The transporter flips guanine through the membrane.
After binding, the transporter undergoes conformational changes to move guanine across the lipid bilayer. This process can be driven by proton or sodium gradients, as seen in SLC15 family transporters. In Paenibacillus larvae, Aza-guanine transporters mediate uptake of aza-guanine, a toxic analog, suggesting a proton-coupled mechanism. The translocation step is rate-limiting and can be regulated by substrate availability and membrane potential.
Intracellular Release and Salvage
In simple terms: Once inside, guanine is released for use in making nucleotides.
Following translocation, guanine is released into the cytoplasm where it enters purine salvage pathways. In Plasmodium falciparum, PfNT1-mediated guanine transport is essential for incorporation into nucleotides, as genetic disruption of PfNT1 impairs parasite growth. In mammalian astrocytes, transported guanine can be converted to guanosine and other purines, supporting neuronal function. The released guanine is rapidly metabolized by HGPRT or other salvage enzymes.
Regulation and Feedback
In simple terms: The cell can speed up or slow down guanine transport as needed.
Guanine transport activity can be modulated by substrate concentration, hormonal signals, and cellular energy status. In rat cortical astrocytes, guanine uptake is inhibited by excess guanosine, suggesting competitive regulation. In plants, cytokinin transporters (AZGs) are regulated during development and in response to environmental cues. The SLC35F2 transporter is subject to regulation by oncogenic signals, linking guanine transport to cancer metabolism. Feedback inhibition by downstream metabolites may also control flux through this pathway.
Key Genes Involved in GO:0015854 guanine transport
The following genes and proteins are experimentally implicated in guanine transport or related nucleobase transport processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PfNT1 | Equilibrative nucleoside transporter in Plasmodium falciparum; transports guanine, xanthine, guanosine, adenine | Essential for parasite purine salvage; validated drug target |
| SLC35F2 | High-specificity transporter for queuine and queuosine; related to guanine transport | Oncogene; links guanine transport to tRNA modification and cancer |
| AZG transporters | Aza-guanine transporters from Paenibacillus larvae; proton-coupled uptake | Model for bacterial nucleobase transport and antibiotic prodrug activation |
| AZG1/AZG2 (plants) | Cytokinin transporters; structurally related to guanine transporters | Regulate plant development and cytokinin distribution |
| SLC15A1 (PEPT1) | Proton-coupled oligopeptide transporter; transports prodrugs and nucleobase analogs | Pharmacological relevance for drug delivery |
| SLC15A2 (PEPT2) | Proton-coupled oligopeptide transporter; expressed in kidney and brain | Prodrug transport and drug disposition |
| NAT family members | Nucleobase-ascorbate transporters; transport guanine and other purines | Widely distributed in bacteria, fungi, plants, and animals |
| HGPRT | Hypoxanthine-guanine phosphoribosyltransferase; salvages guanine into GMP | Deficiency causes Lesch-Nyhan syndrome; downstream of guanine transport |
| Guanine deaminase | Converts guanine to xanthine; regulates intracellular guanine levels | Affects guanine transport flux and purine homeostasis |
| Equilibrative nucleoside transporters (ENTs) | Transport nucleosides and nucleobases including guanine | Broad substrate specificity; involved in drug uptake |
| Concentrative nucleoside transporters (CNTs) | Sodium-coupled nucleoside and nucleobase transport | Potential guanine transport activity in mammals |
| Nucleoporins | Components of nuclear pore complex; mediate nucleocytoplasmic transport | Model for directed transport mechanisms |
| Guanine-based amphiphiles | Synthetic ion transporters; mimic guanine transport | Potential antibacterial and anticancer agents |
| Queuine tRNA-ribosyltransferase | Incorporates queuine (a guanine analog) into tRNA | Downstream of SLC35F2-mediated transport |
| Purine salvage enzymes | Convert transported guanine into nucleotides | Targets for antiparasitic and anticancer therapy |
How Is guanine transport Regulated?
Guanine transport is regulated at multiple levels. In Plasmodium falciparum, PfNT1 expression is stage-specific and essential for parasite survival, with genetic disruption leading to impaired growth. In mammalian astrocytes, guanine uptake is inhibited by excess guanosine, indicating competitive regulation. The oncogene SLC35F2 is regulated by cellular demand for queuine/queuosine, linking transport to translational control. In plants, cytokinin transporters (AZGs) are developmentally regulated and responsive to environmental signals. Additionally, proton-coupled transporters like SLC15 family members are regulated by pH and substrate availability. These regulatory mechanisms ensure that guanine transport matches cellular needs for purine nucleotides and tRNA modification.
guanine transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PfNT1 | Malaria; essential for parasite purine salvage | Plasmodium falciparum knockout or point mutation |
| SLC35F2 | Cancer; oncogene; queuine/queuosine transport | Cancer cell line overexpression or knockout |
| AZG transporters | Honey bee pathogen infection; aza-guanine toxicity | Paenibacillus larvae knockout |
| HGPRT | Lesch-Nyhan syndrome; guanine salvage defect | Patient-derived fibroblasts or CRISPR knock-in |
| SLC15A1/2 | Drug disposition; prodrug transport | Knockout mouse models or cell lines |
Parasitic Infections
Plasmodium falciparum relies on PfNT1 for guanine transport and purine salvage, making it a critical target for antimalarial drugs. Genetic evidence shows that PfNT1 is essential for the transport and utilization of xanthine, guanine, guanosine, and adenine, and its disruption impairs parasite proliferation. Similarly, Aza-guanine transporters in Paenibacillus larvae, a honey bee pathogen, mediate uptake of toxic guanine analogs, which could be exploited for control.
Cancer
SLC35F2 is an oncogene that functions as a high-specificity transporter for queuine and queuosine, micronutrients involved in tRNA modification. Its transport activity supports translational fidelity and may contribute to tumorigenesis by sustaining high metabolic demands. Targeting SLC35F2-mediated transport could disrupt cancer cell metabolism and protein synthesis.
Neurological Disorders
In the brain, guanine and guanosine transport in astrocytes and neurons is essential for purine homeostasis and neuromodulation. Dysregulation of guanine transport may contribute to neurodegenerative conditions by altering extracellular purine levels and receptor signaling. Understanding these transport mechanisms could inform therapies for stroke, epilepsy, and other neurological disorders.
From guanine transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PfNT1 essential for guanine transport in Plasmodium? | PfNT1 knockout in P. falciparum |
| Does SLC35F2 specifically transport queuine/queuosine? | SLC35F2 knockout and overexpression in human cell lines |
| What is the role of guanine transport in astrocytes? | Primary rat cortical astrocyte cultures with transport inhibitors |
| How do AZG transporters recognize cytokinins? | AZG point mutations in plant or heterologous systems |
| Can guanine-based amphiphiles transport ions? | Synthetic chemistry and liposome assays |
| What is the substrate specificity of SLC15 transporters? | SLC15A1/2 knockout cell lines and prodrug uptake assays |
How to Study the guanine transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive uptake assay | Transport kinetics and substrate specificity | Characterizing guanine transport in cells |
| CRISPR knockout | Gene essentiality and transport function | Disrupting PfNT1 or SLC35F2 |
| Heterologous expression | Transport activity in a controlled system | Xenopus oocytes or HEK293 cells |
| Fluorescent substrate uptake | Real-time transport activity | High-throughput screening of inhibitors |
| Molecular dynamics simulation | Substrate binding and conformational changes | Modeling transporter mechanisms |
| Complementation assay | Rescue of transport defect by mutant alleles | Structure-function studies |
| Proteomics | Expression and interaction of transporters | Identifying transport complexes |
| Transcriptomics | Gene expression changes under transport stress | Regulatory network analysis |
Radioactive Uptake Assays
Radiolabeled guanine (e.g., [3H]-guanine) is used to measure transport kinetics in cells and membrane vesicles. This method has been applied to characterize guanine transport in rat cortical astrocytes and neurons, revealing saturable and temperature-dependent uptake. It is also used to study PfNT1-mediated transport in Plasmodium falciparum.
Genetic Knockout and Complementation
CRISPR-Cas9 or homologous recombination is used to disrupt transporter genes, followed by complementation with wild-type or mutant alleles. This approach provided genetic evidence for the essential role of PfNT1 in guanine transport and parasite survival. Similar strategies have been used for SLC35F2 and AZG transporters.
Heterologous Expression and Transport Assays
Transporters are expressed in Xenopus oocytes or mammalian cell lines, and substrate uptake is measured using fluorescent or radioactive substrates. This method was used to characterize Aza-guanine transporters from Paenibacillus larvae and SLC35F2. It allows precise determination of substrate specificity and kinetics.
Structural and Computational Modeling
Homology modeling and molecular dynamics simulations complement experimental studies to predict substrate binding sites and translocation mechanisms. These approaches have been applied to nucleobase-ascorbate transporters and SLC15 family members. They guide mutagenesis and drug design efforts.
How CRISPR Can Be Used to Study GO:0015854 guanine transport
Knockout
CRISPR-Cas9 knockout of guanine transporter genes such as PfNT1 or SLC35F2 is used to determine their essentiality for cellular growth and purine salvage. In Plasmodium falciparum, PfNT1 knockout impairs parasite proliferation, validating it as a drug target. In human cancer cells, SLC35F2 knockout reduces queuine/queuosine uptake and affects tRNA modification.
Point Mutation
CRISPR-mediated point mutations are used to dissect substrate binding residues and transport mechanisms. For example, mutating conserved residues in AZG transporters alters cytokinin recognition. Similarly, point mutations in SLC15 transporters affect prodrug transport. These studies provide structure-function insights.
Knock-in
Knock-in of tagged or fluorescently labeled transporters allows real-time imaging of guanine transport in live cells. This approach can be used to track SLC35F2 localization and dynamics. Knock-in of disease-associated mutations in HGPRT can model Lesch-Nyhan syndrome.
Overexpression
Overexpression of guanine transporters in heterologous systems enhances transport activity and facilitates biochemical characterization. Overexpression of PfNT1 in Xenopus oocytes or mammalian cells has been used to study its substrate specificity. Overexpression of SLC35F2 increases queuine uptake and may promote oncogenic growth.
How EDITGENE Supports guanine transport Research
Researchers studying guanine transport-related genes often need to determine whether a candidate gene is causally involved in substrate uptake, purine salvage, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate these investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for guanine transport research.
Frequently Asked Questions About guanine transport
What is guanine transport?
Guanine transport (GO:0015854) is the directed movement of guanine across cellular membranes via specific transporters or pores.
What genes are involved in guanine transport?
Key genes include PfNT1 in Plasmodium falciparum, SLC35F2 in humans, AZG transporters in plants and bacteria, and SLC15 family members.
Why is guanine transport important for parasites?
Parasites like Plasmodium falciparum cannot synthesize purines de novo and rely on guanine transport for survival.
How is guanine transport studied?
Common methods include radioactive uptake assays, CRISPR knockout, heterologous expression, and structural modeling.
What diseases are linked to guanine transport?
Malaria, cancer, and neurological disorders are associated with dysregulated guanine transport.
What is the role of SLC35F2 in guanine transport?
SLC35F2 is a high-specificity transporter for queuine and queuosine, which are guanine-related micronutrients involved in tRNA modification.
Can guanine transport be targeted for drug development?
Yes, PfNT1 and SLC35F2 are potential drug targets for malaria and cancer, respectively.
What is the difference between guanine transport and guanosine transport?
Guanine transport moves the nucleobase guanine, while guanosine transport moves the nucleoside guanosine; some transporters can handle both.
How does CRISPR help study guanine transport?
CRISPR enables knockout, point mutation, knock-in, and overexpression of transporter genes to dissect their function.
What are the key takeaways about GO:0015854?
GO:0015854 is essential for purine salvage, nucleotide metabolism, and is implicated in malaria, cancer, and neurological disorders.
Conclusion
Guanine transport (GO:0015854) is a fundamental biological process that supports purine salvage, nucleotide biosynthesis, and cellular homeostasis across diverse organisms. Its critical role in parasite survival and cancer metabolism makes it an attractive target for therapeutic intervention. Advances in CRISPR-based models and transport assays continue to unravel the molecular mechanisms and regulatory networks governing guanine transport. EDITGENE provides comprehensive services to facilitate these studies and accelerate discovery.
References
- 1. Musumeci D et al.. 2015. Guanine-based amphiphiles: synthesis, ion transport properties and biological activity.. Bioorg Med Chem 23(5):1149-56 PMID: 25638503
- 2. Alexander CR et al.. 2018. The solute transport profile of two Aza-guanine transporters from the Honey bee pathogen Paenibacillus larvae.. FEMS Microbiol Lett 365(7) PMID: 29385571
- 3. Nagasawa K et al.. 2007. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons.. Glia 55(14):1397-404 PMID: 17674371
- 4. Burtnyak L et al.. 2025. The oncogene SLC35F2 is a high-specificity transporter for the micronutrients queuine and queuosine.. Proc Natl Acad Sci U S A 122(25):e2425364122 PMID: 40526720
- 5. Cole CN et al.. 1998. Nucleocytoplasmic transport: driving and directing transport.. Curr Biol 8(11):R368-72 PMID: 9635180
- 6. Tessi TM et al.. 2024. AZGs: a new family of cytokinin transporters.. Biochem Soc Trans 52(4):1841-1848 PMID: 38979638
- 7. El Bissati K et al.. 2008. Genetic evidence for the essential role of PfNT1 in the transport and utilization of xanthine, guanine, guanosine and adenine by Plasmodium falciparum.. Mol Biochem Parasitol 161(2):130-9 PMID: 18639591
- 8. Minhas GS et al.. 2020. Recent advances in understanding prodrug transport through the SLC15 family of proton-coupled transporters.. Biochem Soc Trans 48(2):337-346 PMID: 32219385
